Trinity Biotech (TRIB) Interest Expenses (2009 - 2024)

Trinity Biotech has disclosed Interest Expenses across 16 years of filings, most recently posting -$3.4 million for Q4 2024.

• In Q4 2024, Interest Expenses fell 44.67% year-over-year to -$3.4 million; the TTM figure through Dec 2024 stood at -$8.8 million (up 20.54% YoY), while the FY2025 annual figure was -$21.4 million, down 123.61% from the prior year.
• Interest Expenses came in at -$3.4 million for Q4 2024 at Trinity Biotech, down from -$2.8 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of -$264000.0 in Q1 2024 to a low of -$12.2 million in Q1 2022.
• Average Interest Expenses over 5 years is -$2.9 million, with a median of -$2.3 million recorded in 2023.
• Year-over-year, Interest Expenses slumped 910.08% in 2022 and soared 89.65% in 2024.
• Over 5 years, Interest Expenses stood at -$1.2 million in 2020, then slumped by 145.18% to -$3.0 million in 2021, then advanced by 20.56% to -$2.4 million in 2022, then rose by 1.97% to -$2.3 million in 2023, then tumbled by 44.67% to -$3.4 million in 2024.
• Per Business Quant data, the three most recent Interest Expenses figures were -$3.4 million in Q4 2024, -$2.8 million in Q2 2024, and -$264000.0 in Q1 2024.